Marcos Cesar Florian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marcos Cesar Florian has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Patricia Duarte Deps
Affiliations Department of Social Medicine, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil, Medical Image Bank, Department of Radiology, Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil, Postgraduate Programme in Infectious Diseases (PPGDI), Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil
4 shared publications - Jane Tomimori
Department of Dermatology, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
3 shared publications - Adriano Henrique Pereira Barbosa
Universidade Federal de São Paulo, Brazil
1 shared publication - Amílcar Sabino Damazo
Research Center in Applied Morphology and Immunology (NuPMIA), Faculty of Medicine, University of Brasília (UnB), Brasília 70910-900, Brazil
1 shared publication - Andrea Maia Fernandes de Araújo Fonseca
SEINPE, Secretaria de Saúde da Prefeitura Municipal de Petrolina, Petrolina, Brazil
1 shared publication - Bianca Barros Canhamaque Amorim
Federal University of Espírito Santo Postgraduate Programme in Infectious Diseases, Department of Public Health Vitória, ES, 29047-105
1 shared publication
Latest Publications
- Open Access
- 12 December 2025
- Published by Springer Nature in Research Square
Independent Assessment of the WHO Skin NTDs App: A Suitable Tool for Leprosy Detection
Objective To independently evaluate the World Health Organization (WHO) Skin Neglected Tropical Diseases (NTDs) app as a clinical decision-support tool for detecting leprosy. The primary objective was to determine whether leprosy appeared within the model's Top-5 diagnostic predictions. A secondary objective was to qualitatively analyse diagnostic error patterns. Methods We used a dataset of 439 anonymised clinical images from confirmed leprosy cases (1996–2024), spanning the full Ridley-Jopling spectrum, type 1 and type 2 reactions, and atypical presentations. After excluding 16 images due to processing errors, 423 images were retained: 367 classical leprosy lesions and 56 reactional or atypical leprosy-related presentations. All images were evaluated via the WHO DHIS2 interface. We estimated Top-5 sensitivity (recall) for leprosy and performed a qualitative error analysis focusing on intra-patient inconsistencies and challenging lesion types. Findings: The model achieved an overall Top-5 sensitivity (recall) of 84.9%, with higher sensitivity for classical lesions (87.2%) than for reactional or atypical presentations (69.6%). Qualitative review revealed inconsistent predictions for visually similar lesions from the same patient, and misclassifications concentrated among necrotic, inflammatory, and infiltrative lesions. Conclusion The WHO Skin NTDs app demonstrates substantial promise as a clinical decision-support and educational tool, especially for classical leprosy. Performance gaps for reactional and atypical forms highlight the need for algorithmic refinement. Enhancing dataset diversity, incorporating lesion segmentation, and integrating patient-level context may improve diagnostic robustness.
- 12 December 2025
- Published by Springer Nature in Research Square
Open AccessIndependent Assessment of the WHO Skin NTDs App: A Suitable Tool for Leprosy Detection
Objective To independently evaluate the World Health Organization (WHO) Skin Neglected Tropical Diseases (NTDs) app as a clinical decision-support tool for detecting leprosy. The primary objective was to determine whether leprosy appeared within the model's Top-5 diagnostic predictions. A secondary objective was to qualitatively analyse diagnostic error patterns. Methods We used a dataset of 439 anonymised clinical images from confirmed leprosy cases (1996–2024), spanning the full Ridley-Jopling spectrum, type 1 and type 2 reactions, and atypical presentations. After excluding 16 images due to processing errors, 423 images were retained: 367 classical leprosy lesions and 56 reactional or atypical leprosy-related presentations. All images were evaluated via the WHO DHIS2 interface. We estimated Top-5 sensitivity (recall) for leprosy and performed a qualitative error analysis focusing on intra-patient inconsistencies and challenging lesion types. Findings: The model achieved an overall Top-5 sensitivity (recall) of 84.9%, with higher sensitivity for classical lesions (87.2%) than for reactional or atypical presentations (69.6%). Qualitative review revealed inconsistent predictions for visually similar lesions from the same patient, and misclassifications concentrated among necrotic, inflammatory, and infiltrative lesions. Conclusion The WHO Skin NTDs app demonstrates substantial promise as a clinical decision-support and educational tool, especially for classical leprosy. Performance gaps for reactional and atypical forms highlight the need for algorithmic refinement. Enhancing dataset diversity, incorporating lesion segmentation, and integrating patient-level context may improve diagnostic robustness.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e01122025
Presence of Viable Bacilli in Multibacillary Leprosy After 12 Doses of Multidrug Therapy
Background: We investigated the clinical profiles of patients with multibacillary leprosy treated with at least 12 doses of multidrug therapy (MDT), in whom intact Mycobacterium leprae bacilli were identified in skin biopsies. Methods: Clinical and therapeutic characteristics of 30 patients were analyzed, and their association with bacillary integrity was assessed. Results: Leprosy reactions were commonly observed. Two-thirds of patients completed treatment within 5 years. A strong association was observed between the 12-dose regimen and the presence of intact bacilli. Conclusions: Clinical and laboratory aspects should be considered when deciding to discontinue MDT, particularly if leprosy reactions occur.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e01122025
Open AccessPresence of Viable Bacilli in Multibacillary Leprosy After 12 Doses of Multidrug Therapy
Background: We investigated the clinical profiles of patients with multibacillary leprosy treated with at least 12 doses of multidrug therapy (MDT), in whom intact Mycobacterium leprae bacilli were identified in skin biopsies. Methods: Clinical and therapeutic characteristics of 30 patients were analyzed, and their association with bacillary integrity was assessed. Results: Leprosy reactions were commonly observed. Two-thirds of patients completed treatment within 5 years. A strong association was observed between the 12-dose regimen and the presence of intact bacilli. Conclusions: Clinical and laboratory aspects should be considered when deciding to discontinue MDT, particularly if leprosy reactions occur.
- Open Access
- 4 March 2024
- Published by Journal of Transcatheter Interventions in Journal of Transcatheter Interventions
- Vol. 31, 1-5
Follow-up protocol for patients with delayed skin reactions due to interventional cardiology procedures: follow-up of patients with skin reactions due to radiation
Interventional cardiology procedures can generate high doses of ionizing radiation and delayed skin reactions in patients undergoing complex procedures with a substantial radiation dose level. Since 2014, we have implemented, in the cath lab, the monitoring of patients undergoing procedures with a substantial radiation dose level, to identify these patients and provide patient care support. We present two case reports of such patients, who are undergoing dermatological treatment. The implemented protocol provided specialized treatment for the patients and awareness [...] ABSTRACT Interventional cardiology procedures can generate high doses of ionizing radiation and delayed skin reactions in patients undergoing complex procedures with a substantial radiation dose level. Since 2014, we have implemented, in the cath lab, the monitoring of patients undergoing procedures with a substantial radiation dose level, to identify these patients and provide patient care support. We present two case reports of such patients, who are undergoing dermatological treatment. The implemented protocol provided specialized treatment for the patients and awareness
- 4 March 2024
- Published by Journal of Transcatheter Interventions in Journal of Transcatheter Interventions
- Vol. 31, 1-5
Open AccessFollow-up protocol for patients with delayed skin reactions due to interventional cardiology procedures: follow-up of patients with skin reactions due to radiation
Interventional cardiology procedures can generate high doses of ionizing radiation and delayed skin reactions in patients undergoing complex procedures with a substantial radiation dose level. Since 2014, we have implemented, in the cath lab, the monitoring of patients undergoing procedures with a substantial radiation dose level, to identify these patients and provide patient care support. We present two case reports of such patients, who are undergoing dermatological treatment. The implemented protocol provided specialized treatment for the patients and awareness [...] ABSTRACT Interventional cardiology procedures can generate high doses of ionizing radiation and delayed skin reactions in patients undergoing complex procedures with a substantial radiation dose level. Since 2014, we have implemented, in the cath lab, the monitoring of patients undergoing procedures with a substantial radiation dose level, to identify these patients and provide patient care support. We present two case reports of such patients, who are undergoing dermatological treatment. The implemented protocol provided specialized treatment for the patients and awareness
- 1 September 2023
- Published by Springer Nature
- p. 81-108
Clinical Aspects and Classification of Hansen’s Disease
- 1 September 2023
- Published by Springer Nature
- p. 81-108
Clinical Aspects and Classification of Hansen’s Disease
- 1 September 2023
- Published by Springer Nature
- p. 1-8
Introduction to Hansen’s Disease
- 1 September 2023
- Published by Springer Nature
- p. 301-312
Treatment of Hansen’s Disease
- 1 September 2023
- Published by Springer Nature
- p. 275-280
Immune and Chemoprophylaxis in Hansen’s Disease
- 1 September 2023
- Published by Springer Nature
- p. 275-280
Immune and Chemoprophylaxis in Hansen’s Disease
- 15 November 2022
- Published by Springer Nature
- p. 115-141
Mycobacterial Diseases
- Open Access
- 24 June 2020
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 24 (4) , 296-303
Association between NDO-LID and PGL-1 for leprosy and class I and II human leukocyte antigen alleles in an indigenous community in Southwest Amazon
- 24 June 2020
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 24 (4) , 296-303
Open AccessAssociation between NDO-LID and PGL-1 for leprosy and class I and II human leukocyte antigen alleles in an indigenous community in Southwest Amazon